Raras
Buscar doenças, sintomas, genes...
Elastose perfurante serpiginosa
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

THOUGHTS: The user wants a translation of a medical description into Brazilian Portuguese. I need to ensure medical terms are correctly translated and that the flow is natural for the target language. I also need to make sure to respond *only* with the translation, no extra text or markdown. - "Elastosis perforans serpiginosa": This is a medical condition name. I should keep it as is, or use a common Portuguese translation if one exists. "Elastose perfurante serpiginosa" is the standard translation. - "is a unique perforating disorder": "é uma doença perfurante única" or "é uma condição perfurante singular". "Doença" is more common than "condição" in this context when describing a disorder. - "characterized by transepidermal elimination of elastic fibers": "caracterizada pela eliminação transepidérmica de fibras elásticas". This is a direct translation and correct. - "and distinctive clinical lesions": "e lesões clínicas distintas" or "e lesões clínicas características". "Distintas" or "características" both work well. "Distintas" is a bit closer to "distinctive". - "which are serpiginous in distribution": "que apresentam distribuição serpiginosa". "Serpiginosa" is the correct medical term. "Apresentam distribuição" sounds natural. - "and can be associated with specific diseases": "e podem estar associadas a doenças específicas". This is a direct and correct translation. Let's put it together: "Elastose perfurante serpiginosa é uma doença perfurante única, caracterizada pela eliminação transepidérmica de fibras elásticas e por lesões clínicas distintas, que apresentam distribuição serpiginosa e podem estar associadas a doenças específicas." I need to make sure to output *only* the translation.

Publicações científicas
230 artigos
Último publicado: 2026 Mar 25

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: L87.2
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧬
Pele e cabelo
6 sintomas
😀
Face
1 sintomas

+ 6 sintomas em outras categorias

Características mais comuns

90%prev.
Morfologia anormal do pescoço
Muito frequente (99-80%)
90%prev.
Pápula hiperceratótica
Muito frequente (99-80%)
55%prev.
Lesão cutânea serpiginosa
Frequente (79-30%)
55%prev.
Pápula eritematosa
Frequente (79-30%)
55%prev.
Anormalidade da face
Frequente (79-30%)
55%prev.
Lesão cutânea anular
Frequente (79-30%)
13sintomas
Muito frequente (2)
Frequente (6)
Ocasional (3)
Sem dados (2)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 13 características clínicas mais associadas, ordenadas por frequência.

Morfologia anormal do pescoçoAbnormality of the neck
Muito frequente (99-80%)90%
Pápula hiperceratóticaHyperkeratotic papule
Muito frequente (99-80%)90%
Lesão cutânea serpiginosaSerpiginous cutaneous lesion
Frequente (79-30%)55%
Pápula eritematosaErythematous papule
Frequente (79-30%)55%
Anormalidade da faceAbnormality of the face
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico230PubMed
Últimos 10 anos66publicações
Pico20168 papers
Linha do tempo
2026Hoje · 2026📈 2016Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Elastose perfurante serpiginosa

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
56 papers (10 anos)
#1

Penicillamine-induced elastosis perforans serpiginosa.

Journal of the European Academy of Dermatology and Venereology : JEADV2026 Mar 25
#2

Dermoscopy of Acquired Perforating Dermatoses: A Case Series and Review of the Literature.

Life (Basel, Switzerland)2025 Nov 21

Acquired perforating dermatoses (APD) represent a group of papulonodular skin disorders characterized by transepidermal elimination of dermal components, most frequently arising in patients with poorly controlled chronic systemic conditions such as diabetes mellitus (DM) and chronic renal failure (CRF). The four classical subtypes include acquired reactive perforating collagenosis (RPC), Kyrle's disease (KD), elastosis perforans serpiginosa (EPS), and perforating folliculitis (PF). Owing to their rarity and the often-complex comorbidities of affected individuals, accurate diagnosis of APD may be challenging. In this context, dermoscopy has emerged as a valuable noninvasive tool that enhances diagnostic accuracy and supports clinical decision-making. This study aimed to characterize the dermoscopic features of APD through a case series and subsequent literature review. We present clinical and dermoscopic findings from a case series of 10 patients with APD followed by a literature review of 17 published case reports and 2 case series. The predominant dermoscopic pattern comprised a central yellow-to-brown structureless area, a surrounding white rim or a broader white structureless area with or without scaling, and an outer erythematous area containing dotted or hairpin vessels. Variations in these features appeared to reflect different stages of lesion evolution. The findings reinforce dermoscopy as a useful adjunct for the recognition, characterization, and monitoring of APD, providing additional insights into disease progression and contributing to improved diagnostic accuracy and clinical management.

#3

Coexisting elastosis perforans serpiginosa and acquired cutis laxa following long-term penicillamine in Wilson disease.

Skin health and disease2025 Dec

We report a rare case of coexisting elastosis perforans serpiginosa and acquired cutis laxa in a patient with Wilson's disease following prolonged penicillamine therapy. This represents two rare but important dermatologic complications of long-term chelation therapy that clinicians should be aware of, given the potential for underlying elastin disruption to also affect systemic tissues.

#4

Elastosis Perforans Serpiginosa Is Not a Cutaneous Manifestation of Marfan Syndrome.

Cureus2025 Jul

Elastosis perforans serpiginosa is a perforating dermatosis that morphologically presents as serpiginous, annular, or curved papules and plaques whose pathologic examination demonstrates the transepidermal elimination of elastic fibers. The perforating dermatosis can be idiopathic or induced by drug exposure: most commonly, D-penicillamine. Occasionally, elastosis perforans serpiginosa is associated with a connective tissue disease. Individuals with Marfan syndrome have a defect in the FBN1 gene, which produces fibrillin. The connective tissue disease can occur spontaneously or is usually inherited in an autosomal dominant manner. Major criteria for the diagnosis of Marfan syndrome include aortic root dilatation and ectopia lentis. Patients often have musculoskeletal abnormalities, other cardiovascular features, and/or other ocular manifestations. A common cutaneous manifestation of Marfan syndrome is striae distensae on the deltoid, pectoral, and/or thigh regions. Numerous textbooks and publications have stated that elastosis perforans serpiginosa is associated with Marfan syndrome. However, the bona fide coexistence of elastosis perforans serpiginosa and Marfan syndrome has only been documented in a 23-year-old woman. She not only had biopsy-confirmed elastosis perforans serpiginosa but also skeletal abnormalities (arachnodactyly, genu valgum, and kyphoscoliosis) and numerous eye findings of Marfan syndrome. An investigation using the medical search engine PubMed for "elastosis perforans serpiginosa and Marfan syndrome" does not yield any relevant citations. Therefore, to the best of my knowledge, the literature only contains the coincidental observation of elastosis perforans serpiginosa and Marfan syndrome in a single patient. In conclusion, elastosis perforans serpiginosa is not a cutaneous manifestation of Marfan syndrome.

#5

Elastosis perforans serpiginosa in a child with Down syndrome.

Archives of disease in childhood2025 Jun 19

Publicações recentes

Ver todas no PubMed

📚 EuropePMC171 artigos no totalmostrando 66

2026

Penicillamine-induced elastosis perforans serpiginosa.

Journal of the European Academy of Dermatology and Venereology : JEADV
2025

Dermoscopy of Acquired Perforating Dermatoses: A Case Series and Review of the Literature.

Life (Basel, Switzerland)
2025

Coexisting elastosis perforans serpiginosa and acquired cutis laxa following long-term penicillamine in Wilson disease.

Skin health and disease
2025

Elastosis Perforans Serpiginosa Is Not a Cutaneous Manifestation of Marfan Syndrome.

Cureus
2025

Elastosis perforans serpiginosa in a child with Down syndrome.

Archives of disease in childhood
2025

Clinical characteristics of elastosis perforans serpiginosa: A retrospective review.

Journal of the American Academy of Dermatology
2025

New findings of dermoscopy and reflectance confocal microscopy for perforating pseudoxanthoma elasticum with elastosis perforans serpiginosa-like changes.

JAAD case reports
2024

Cabozantinib-associated acquired perforating dermatosis.

JAAD case reports
2024

Growing Periumbilical Plaque: A Case of Perforating Calcific Elastosis.

Cutis
2024

Recalcitrant Reactive Perforating Collagenosis Successfully Treated with Dupilumab: A Case Report.

Clinical, cosmetic and investigational dermatology
2024

Penicillamine-Induced Localised Cutis Laxa in a Patient with Wilson Disease: A Case Report.

Mediterranean journal of rheumatology
2024

Sustained improvement of elastosis perforans serpiginosa after isotretinoin therapy.

JAAD case reports
2023

Kyrle disease: a case report and literature review.

European review for medical and pharmacological sciences
2023

Miscellaneous annular diseases.

Clinics in dermatology
2023

A Systematic Review of Case Reports of a Rare Dermatological Condition: Elastosis Perforans Serpiginosa.

Cureus
2022

Neu entdeckte Genmutation beim Ehlers-Danlos-Syndrom mit Elastosis perforans serpiginosa.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2022

Newly detected gene mutation in Ehlers-Danlos syndrome with elastosis perforans serpiginosa.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2023

Generalized scleroderma-like induration associated with D-penicillamine elastosis perforans serpiginosa in Wilson's disease.

International journal of dermatology
2022

Elastoma of the Orbit: A Case Report.

Ophthalmic plastic and reconstructive surgery
2022

Common Dermatologic Disorders in Down Syndrome: Systematic Review.

JMIR dermatology
2021

Penicillamine-induced elastosis perforans serpiginosa and pseudo-pseudoxanthoma elasticum.

International journal of women's dermatology
2021

Treatment of a perforating dermatosis with apremilast.

JAAD case reports
2022

Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products.

Clinical and experimental dermatology
2021

The dermatological aspects of hEDS in women.

International journal of women's dermatology
2020

Elastosis Perforans Serpiginosa: a D-penicillamine induced dermatoses in a patient with Wilson's disease.

Autopsy &amp; case reports
2021

Treatment of extensive elastosis perforans serpiginosa with acitretin in a man with Down syndrome.

International journal of dermatology
2020

Clinical practice guide for the treatment of perforating dermatosis.

The Journal of dermatology
2021

A case of acquired disseminated elastosis perforans serpiginosa in a patient with HIV, hepatitis B and hepatitis C successfully treated with narrowband ultraviolet B therapy.

Clinical and experimental dermatology
2020

A case of elastosis perforans serpiginosa associated with long-term treatment with penicillamine.

International journal of dermatology
2020

Elastosis perforans serpiginosa induced by d-penicillamine treated with cyclosporine and allopurinol.

Dermatologic therapy
2019

Pulse Dye Laser Therapy Successful for Elastosis Perforans Serpiginosa.

Case reports in dermatological medicine
2020

Severe early-onset manifestations of pseudoxanthoma elasticum resulting from the cumulative effects of several deleterious mutations in ENPP1, ABCC6 and HBB: transient improvement in ectopic calcification with sodium thiosulfate.

The British journal of dermatology
2019

Periumbilical Papules in a Middle-aged Woman.

JAMA dermatology
2020

Arcuate pink plaques in a female with Down syndrome.

International journal of dermatology
2019

Elastosis perforans serpiginosa related to vascular Ehlers-Danlos syndrome.

Dermatology online journal
2019

D-penicillamine-induced pseudo-pseudoxanthoma elasticum and extensive elastosis perforans serpiginosa with excellent response to acitretin.

Annals of Saudi medicine
2019

Cutaneous Elastic Tissue Anomalies.

The American Journal of dermatopathology
2018

Perforating dermatosis associated with multikinase inhibitors: report of two cases, including one associated with lenvatinib.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2018

Dermatological aspects of the S2k guidelines on Down syndrome in childhood and adolescence.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2018

Dermatologische Aspekte aus der S2k-Leitlinie zum Down-Syndrom im Kindes- und Jugendalter.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2018

Keratotic papules in an annular arrangement.

JAAD case reports
2018

Elastosis perforans serpiginosa: causes and associated disorders.

European journal of dermatology : EJD
2018

Erythematous Papular Lesions on the Neck: A Quiz.

Acta dermato-venereologica
2018

A case of paraneoplastic elastosis perforans serpiginosa associated with ovarian malignancy.

International journal of dermatology
2018

Idiopathic elastosis perforans serpiginosa with satisfactory response after 5-ALA photodynamic therapy.

Photodiagnosis and photodynamic therapy
2017

Hidradenitis Suppurativa and Concomitant Down Syndrome: Literature Review of Other Associated Mucocutaneous Manifestations in Adults.

Skinmed
2017

D-penicillamine-induced Elastosis Perforans Serpiginosa.

Chinese medical journal
2017

Treatment of Elastosis Perforans Serpiginosa Using a Fractional Carbon Dioxide Laser.

JAMA dermatology
2017

No rubbing, no elastosis perforans serpiginosa.

The Journal of dermatology
2017

Elastosis perforans serpiginosa in a patient with Wilson's disease.

The lancet. Gastroenterology &amp; hepatology
2017

Non-Healing Perianal Ulcers in a Healthy Elderly Male: An Unusual Case of Perforating Dermatosis.

Journal of cutaneous medicine and surgery
2016

Acquired perforating dermatosis in a patient with chronic renal failure.

Anais brasileiros de dermatologia
2017

Giant variant of acquired perforating dermatosis in a renal dialysis patient.

JAAD case reports
2017

Annular Plaques With Skin Atrophy in a Young Patient.

JAMA dermatology
2016

Elastosis perforans serpiginosa: a review of the literature and our own experience.

Postepy dermatologii i alergologii
2016

Perforating pseudoxanthoma elasticum with secondary elastosis perforans serpiginosa-like changes: dermoscopy, confocal microscopy and histopathological correlation.

Journal of cutaneous pathology
2016

Dermoscopy and direct immunofluorescence findings of elastosis perforans serpiginosa.

Clinical and experimental dermatology
2016

[Elastosis Perforans Serpiginosa and Wilson Disease: A Rare but Predictable Consequence of Long-term Therapy with D-Penicillamine].

Acta medica portuguesa
2016

Two cases of D-penicillamine-induced elastosis perforans serpiginosa.

Indian journal of dermatology, venereology and leprology
2016

Elastosis perforans serpiginosa in a case of pseudoxanthoma elasticum: A rare association.

Indian dermatology online journal
2016

Elastophagocytosis and Elastolysis in Leprosy.

Indian journal of leprosy
2015

Drug-induced elastosis perforans serpiginosa.

BMJ case reports
2015

Annular keratotic papules on the extremities.

Journal of the American Academy of Dermatology
2015

Fifty shades of yellow: a review of the xanthodermatoses.

International journal of dermatology
2015

Scaly Erythematous Patches in a Patient With Down Syndrome.

Actas dermo-sifiliograficas
2015

Dermoscopy of elastosis perforans serpiginosa: A useful tool to distinguish it from granuloma annulare.

Journal of the American Academy of Dermatology
Ver todos os 171 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Elastose perfurante serpiginosa.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Elastose perfurante serpiginosa

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Penicillamine-induced elastosis perforans serpiginosa.
    Journal of the European Academy of Dermatology and Venereology : JEADV· 2026· PMID 41879094mais citado
  2. Dermoscopy of Acquired Perforating Dermatoses: A Case Series and Review of the Literature.
    Life (Basel, Switzerland)· 2025· PMID 41465726mais citado
  3. Coexisting elastosis perforans serpiginosa and acquired cutis laxa following long-term penicillamine in Wilson disease.
    Skin health and disease· 2025· PMID 41312328mais citado
  4. Elastosis Perforans Serpiginosa Is Not a Cutaneous Manifestation of Marfan Syndrome.
    Cureus· 2025· PMID 40809613mais citado
  5. Elastosis perforans serpiginosa in a child with Down syndrome.
    Archives of disease in childhood· 2025· PMID 40514189mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:79148(Orphanet)
  2. OMIM OMIM:130100(OMIM)
  3. MONDO:0007529(MONDO)
  4. GARD:10103(GARD (NIH))
  5. Busca completa no PubMed(PubMed)
  6. Q5353584(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Elastose perfurante serpiginosa
Compêndio · Raras BR

Elastose perfurante serpiginosa

ORPHA:79148 · MONDO:0007529
Prevalência
Unknown
CID-10
L87.2 · Elastose perfurante serpiginosa
CID-11
Início
All ages
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0221271
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades